VIEW PDF 26 SEPT 2016: Valley View, OH – Great Lakes NeuroTech (GLNT) today announced plans to collaborate with the pharmaceutical company UCB to provide individuals with Parkinson’s Disease (PD) and their clinicians with improved quantitative tools for assessing the…
Blog Archives
WEARABLE TECHNOLOGY IN PARKINSON’S DISEASE DEMONSTRATES INCREASED REFERRAL RATE FOR ADVANCED THERAPY
VIEW PDF 20 JUL 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has completed and published a clinical study validating that remote monitoring with wearable, objective measures can lead to an increased referral rate for advanced therapies in Parkinson’s…
GREAT LAKES NEUROTECH VALIDATION STUDIES ON WEARABLE TECH FOR PARKINSON’S TO BE HIGHLIGHTED AT MOVEMENT DISORDER SOCIETY ANNUAL MEETING IN BERLIN
VIEW PDF 15 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that three scientific research studies validating Kinesia wearable tech for Parkinson’s disease applications will be highlighted at the 20th International Congress of Parkinson’s Disease and…
GREAT LAKES NEUROTECH ISSUED 4 PATENTS COVERING WEARABLES FOR MEASURING SYMPTOMS, ADJUSTING THERAPIES, AND DATABASE LEARNING IN PARKINSON’S DISEASE
VIEW PDF 10 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they have received four issued patents from the U.S. Patent Office, focused on wearable technology for Parkinson’s disease diagnostics and treatment. The issued intellectual property…
Great Lakes NeuroTech Allowed Patent Claims for Deep Brain Stimulation Visualization Maps
VIEW PDF 14 OCT 2015: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they have received a new allowance of claims from the U.S. Patent Office, focused on technology for Parkinson’s disease diagnostics and treatment. This particular application…
Great Lakes NeuroTech Secures $1.9M for Closed-Loop Programming of Deep Brain Stimulation in Parkinson’s with Wearable Sensors
View PDF 21 SEP 2015: Cleveland, OH – Great Lakes NeuroTechnologies (GLNT), announced they have received $1.9M from the National Institutes of Health to improve the efficacy of deep brain stimulation (DBS) programming for Parkinson’s disease (PD) and minimize time…
Wearables and Apps for Parkinson’s disease: Why Big Data and Big Names May Not Be Small Enough
VIEW PRESS RELEASE PDF 17 MAR 2015: Cleveland, OH – While headlines recently surged over big organizations such as Intel, Apple, and the Michael J. Fox Foundation partnering to launch pilot studies on wearables, mobile apps, and big data for…
PRESS RELEASE: Great Lakes NeuroTech Pilot Studies Demonstrate Computer Guided Algorithms for Programming Deep Brain Stimulation in Parkinson’s Disease
VIEW PRESS RELEASE PDF 06 FEB 2015: Valley View, OH – Great Lakes NeuroTechnologies announced today they have completed two pilot studies [ http://glneurotech.com/kinesia/validation/dbs-pilot-study/ ] demonstrating computer-guided algorithms for programming deep brain stimulation (DBS) in Parkinson’s disease. The first study,…
PRESS RELEASE: Great Lakes NeuroTech Enters Medical Device App Market with Kinesia One for Monitoring Parkinson’s Disease
VIEW PRESS RELEASE 12 NOV 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have successfully transitioned their Kinesia technology for objective monitoring of Parkinson’s disease to an app platform. Kinesia ONE™ [http://glneurotech.com/kinesia/] uses a patient worn sensor…
PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps
VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with…
Posted in Blog, Funding, Kinesia, News, Press Tagged with: app, dbs, deep brain stimulation, fda, kinesia, mobile, nih, parkinson's disease, parkinson's telemedicine, remote, rigidity, sensor, telemedicine, therapy, tremor